Connect with us

Business

Stories from the pandemic: How Covid-19 affected lives of a cross-section of people

Published

on

Stories from the pandemic: How Covid-19 affected lives of a cross-section of people

A 32-year-old who recovered from Covid-19 in Bihar. A preacher in Manipur who is thankful that all his contacts have tested negative. A doctor in Kerala who is keeping himself updated on the latest developments. A retired teacher flying from the US on a Vande Bharat flight. All of them have been directly or indirectly affected by the pandemic. Here are their stories:

Deepak Kumar, 32, operation executive with a private firm, Patna

Picture 111

It is just seasonal cough and cold, Deepak Kumar was told by his doctor. But soon he landed up at the Nalanda Medical College & Hospital in Patna along with his parents. All three tested positive for Covid-19. “The sight of the ward, which used to be a deaddiction unit, made us feel sicker. The toilet had no door. There were no bed sheets or ceiling fans and the mattresses were torn. We were given disposable masks every third or fourth day. Not even a nurse passed by to ask about our well-being on the first day,” he recalls.

With no dinner served the first night, they went to bed eating Parle-G biscuits, says Kumar. The next morning they were shifted to the skin ward, which at least had bed sheets and a ceiling fan and a common washroom with a door. “Since the sweeper refused to clean it, we did it ourselves. Water, if demanded today, was given the next day.” In seven days, his father and mother were discharged.

Advertisement

Kumar says there was no sanitiser in the hospital. “As for medicines, I was given azithromycin 500 mg, paracetamol, two tablets of Vitamin C and D, all wrapped in a paper and thrown at me for the first four days. Fifth day onward, I was given only Vitamin C and D tablets. Two days later, two tablets of hydroxychloroquine were given for four-five days.” In 14 days, he too was discharged.

“The ambulance dropped me a kilometre from my house,” he says. “More than Covid, I feel I have survived the filthy ward of Bihar.”

Maulana Haji Abdur Rehman, 53,Religious preacher, Thoubal, Manipur

Advertisement
Picture 222

Haji Abdur Rehman was happy to be back with his wife and children in Manipur’s Thoubal town. He had returned from Nizamuddin Markaz, Delhi, on March 11. A week later, Rehman, his wife and 10 kids were at the Covid-19 ward of RNC Hospital in Imphal, after he was traced and tested.

“There are no outcry around Covid-19 when I went to attend the congregation in early March,” recalls Rehman. Three days after his return from Delhi, Rehman had cough, sore throat, fever, weakness and high blood sugar. “I am diabetic and had tuberculosis in 2016; so I thought maybe the TB was back. My doctor thought the symptoms could be due to diabetes and gave medicines accordingly, which did not help much.” Soon he was taken to the government hospital by health department officials.

“The first two days I was given Vitamin B and C tablets. On Day 3, I had to take some pills twice a day. I was told these were to treat Covid-19.” He suspects these were hydroxychloroquine. “My room was clean. Meals were simple and we got an egg with breakfast. I started feeling better from the sixth day. Doctors came to see me every few hours. A nurse was always stationed outside my room, should I need anything. What more could a sick person want?” asks Rehman.

After testing negative thrice, he was discharged after 15 days. “I am happy that none of my 100-odd contacts, including my children, tested positive.” Will he resume his work after the lockdown? “It is up to my religious leaders in Manipur and Nizamuddin. I simply follow their advice.”

Advertisement

Sushila Kataria, 43, Director of Internal Medicine, Medanta, Gurgaon, Haryana

Picture 333

Sushila Kataria, director of internal medicine at Medanta, Gurgaon, and head of a group of doctors treating Covid patients at Medeor Hospital, Manesar, must have seen at least 80 Covid patients between the two hospitals by now.

“Every morning we devise a strategy for each patient: on who needs which medicines and what tests.” Medicines include paracetamol, Vitamin B, C, D and zinc tablets, hydroxychloroquine, tocilizumab and sometimes azithromycin. Kada (a concoction of herbs and spices) was given only to those who were participating in ayurvedic trials.

“We closely analyse patients who need neurological support or have comorbidity. If there is any deterioration, immediate decisions are taken,” she says.

Advertisement

But things were different on March 3 when she started treating her first Covid patient from Italy at Medanta. “We only had early results of clinical trials from China and Italy. I spoke to doctors in Italy to find out their line of treatment but the situation there was worse. There is no standard treatment for Covid patients and since we are part of clinical trials, we have to follow certain protocols. With the Italian patient, we also set up an ICU in the ward itself. A 24-hour camera was put above him so I could monitor him even from home.”

She carries her share of anxieties home. “I try and keep to my room. My children — aged 13 and 16 — understand the situation.” For someone who has treated 80 patients over 75 days, she knows that this virus is here to stay. “One day I will get the virus. So why not perform my duty well first?”

Haimanty Dattagupta, 81,Retired teacher evacuated by Vande Bharat Mission

Advertisement
Picture 444

The huge San Francisco International Airport was eerily empty and silent when I reached on May 13 to check in for the special flight evacuating stranded Indians. The only hub of activity was the Air India check-in counter.

I was visiting my daughter in the US and the disruption of flights had been a source of concern. My regular prescription medicine was dwindling. I was also worried about my visitor visa becoming invalid. It was a big relief when the consulate general of San Francisco said I had been selected for evacuation. The checkin at SFO airport took several hours but officials ensured that medical check-up and other processes were carried out efficiently. Social distancing was maintained and all the officials and passengers wore masks and gloves. Our temperature was checked and doctors asked us about our health condition.

In the plane we were given bags with dry food packets, water bottle and a plastic face cover. I was in the business class; a screen separated my fellow passenger and me. The crew were all in protective gear and the usual services were not offered. Passengers using washrooms were told not to queue up on the aisle.

At Delhi, disembarkation took almost an hour, as passengers had to move slowly, maintaining distance. We had to use plastic face covers over masks. The process of health check, immigration and boarding the buses for hotels where we had to be quarantined for 14 days took over four hours. At the hotel, I cannot leave my room. The staff leave the food outside my room in disposable containers. I’m reading, making video calls and keeping abreast of news on my tablet.

Advertisement

(Haimanty is the mother of ET Magazine reporter Ishani Duttagupta. This account is as told to Ishani)

Rohit Dutta, 45, businessman, New Delhi

Picture 555

Rohit Dutta is “very busy” these days. He is playing snake and ladder with his daughter. “Covid-19 has changed my perspective. Family time is indispensable for me now.”

When he developed sore throat and fever after returning from Italy in February, his doctor dismissed it as flu. When there was no relief, he got himself admitted to Ram Manohar Lohia Hospital, Delhi. There were two others with him. “When their tests came negative, I too packed my stuff. But the doctor said I will be shifted to Safdarjung hospital.

Advertisement

“At Safdarjung, three doctors in PPE kits broke the news that I was positive and counselled me at the same time. All of my 50-odd contacts were traced; they tested negative.” Meanwhile, his cough got worse and by the third day, he had a coughing fit when he spoke. “But switching my phone off was out of the question as it was the only connection with my family.”

He says, “Since those were early days, there were no clear protocols for treatment. Doctors weren’t very sure of what to administer though they were very attentive and responsive. I was given only antiflu tablets. Diet was simple and milk was given once a day.”

As he goes back for a game of Ludo with his two kids, he says, “At the hospital, I could only see my children on video calls. When I got back home, I was on quarantine. I still could not hug them. I wondered which was worse — staying at the hospital or at home without being able to embrace my children?”

Advertisement

Umesh Shah, 70, former businessman, Ahmedabad, Gujarat

Picture 666

Umesh Shah, 70, first had stomach pain. The next day, fever set in. Shah had rarely stepped out of his home except to get milk from a shop next-door every evening. “I got myself tested for Covid-19 at a private lab in Ahmedabad. I was positive.” Acting proactively and fearing for the safety of his wife, he called the Civil Hospital who sent an ambulance in no time. He was hospitalised and his wife quarantined.

“I was given oxygen from the first day of my hospitalisation as I had trouble breathing. I was shifted to the ICU on Day 3. My medicines were routine: Vitamin C, folic acid and Vitamin B complex tablets. Some fluids were also injected on a daily basis. I was definitely not given hydroxychloroquine,” he says.

In the morning, he was given kada — a concoction of herbs and spices — followed by chai-biscuit, and breakfast with egg. A simple lunch was followed by tea and biscuits again around 4 pm. “Dinner was always served with warm milk.”

Advertisement

Shah says doctors came round the clock to enquire about his health. “For X-ray and ECG, machines were brought to the ward itself.” Not being charged a single penny for his 23-day stay was another relief for Shah, a former businessman. “Had I gone at other times, I’m sure I would have been charged `3-4 lakh.”

Shah says that in his more than threeweek stay, he saw or heard of 15 Covid-19 deaths in that hospital. “Sometimes I would feel down and out. But soon I would think of my wife and wanted to live and be back home with her.”

At home, Shah still tries to figure out how he contracted the virus but he hasn’t got any clear answers. “I think I was just destined to test positive for Covid-19 and get cured positively.”

Advertisement

Sharath Thomas Roy, 33, Doctor at Pathanamthitta General Hospital, Kerala

Picture 777

We began treating Covid-19 patients at our hospital in Pathanamthitta from March 6. Based on what we read in various medical journals, discussions with colleagues here and abroad and rough guidelines from the Kerala government, we treated them mainly with three drugs: Fluvir, an antiviral drug used for flu; azithromycin, which is an antibiotic; and hydroxychloroquine.

We noticed that while patients below 40 years had mild symptoms, those above 40 years had fever, cough and breathlessness in the initial stages. Once we put them on the three-drug regimen, they began responding slowly, after three days or so.

Since we were dealing with a new virus, we kept ourselves updated through various webinars. I have attended more webinars in the past two months than in my two years of MD.

Advertisement

We are a team of three doctors and have treated 19 patients so far. The biggest challenge has been keeping their spirits up. Right now, we have five patients, and one of them was admitted when she was pregnant. She delivered her baby but she is struggling with postpartum depression and guilt that she cannot breast-feed. Changing the patient’s mood is tough — imagine being stuck alone in a room for over 20 days, with the only person you meet being someone in a PPE kit whose face you can’t see properly. In some cases, we had to take the help of our psychiatrist.

Personally, I was apprehensive at the beginning because both my parents are above 60, my father is diabetic and my wife was carrying at that time. As soon as I reach home, I wash myself in a bathroom outside and change my clothes before going inside.

To be frank, we are more scared now. People seem to have a false faith — they think that Covid-19 is like any other disease, that they can be cured easily. When the lockdown began easing, people were wearing masks and maintaining social distancing, but now it’s like any other day. If people become careless, the situation will definitely go out of hand.

Advertisement

Advertisement

 

(Note: This is a Article Automatically Generated Through Syndication, Here is The Original Source

Advertisement

Passionate news enthusiast with a flair for words. Our Editorial Team author brings you the latest updates, in-depth analysis, and engaging stories. Stay informed with their well-researched articles.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

‘Dear Prachi’ Ad By Bombay Shaving Company Faces Backlash From Netizens , Here’s What The CEO Says

Published

on

'Dear Prachi' Ad Bombay Shaving Company Faces Backlash From Netizens , Here's What The CEO Says

Prachi Nigam, the Class 10 UP Board topper from Uttar Pradesh, was brutally trolled by social media users.

People are in disbelief at witnessing a young and intellectual child being trolled because of her facial hair.

Several notable personlities also came forward to support the teen by shutting down the trolls.

Advertisement

While, many also congratulated Prachi Nigam for her exceptional performance.

In the wake of this, an advertisement surfaced on social media by Bombay Shaving Company, adding fuel to the fire.

Even though the intention of the advertisement was to support the teen, it was slammed by the public.

Advertisement

The founder and CEO of Bombay Shaving Company Shantanu Deshpande took to LinkedIn and shared a picture from the topper’s newspaper advertisement.

In the caption, he wrote

“It was shocking to see the amount of hate targeted at a teenage girl who had topped an exam because of her facial hair. Our simple message to this amazing young woman with such a bright future. Love to see my team ooze class. No opportunistic sales, QR codes, nothing. Just a heartfelt message to a fellow Bae.”

The caption further reads,

Advertisement

“Dear Prachi, they’re trolling your hair today, they’ll applaud your AIR tomorrow.”

It was the advertisement’s closing statement that fueled controversy and drew backlash from the public.

It stated,

“We hope you never get bullied into using our razor.”

Netizens’ Reactions

The post went viral within hours of its posting. Many netizens called it “disgusting” and “absurd.”

Advertisement

One user wrote,

“This is a collective failure of your team. Hope they read each and every comment and reflect. Did no one in the team notice this problem? How disconnected are they from reality? This will leave a deeper scar on the girl than anything else, and I will always remember your brand for being an opportunist.”

While another commented, “Insensitive.”

“This is terrible, a huge mistake you made. This is bullying this woman on another, bigger level,”

wrote another. 

Advertisement

“Classless and in poor taste… You don’t deserve more attention than this,”

one commented. 

What the CEO Has to Say?

Shantanu Deshpande described his caption as a small token of support for Prachi, and thus defended the ad.

His efforts to clear the air were in vain, as many netizens still found the company’s response via the ad lacking sensitivity.

Advertisement

Bombay Shaving Company’s intention was to extend support for the topper. However, it ultimately led to more criticism and enhanced controversy.

Recently, the class 10th and 12th results were published by the Uttar Pradesh Madhyamik Shiksha Parishad. Prachi Nigam scored 591/600 marks and topped Class 10. She revealed that her aim is to crack the IIT-JEE and become an engineer.

Also Check: Sachin Sahoo: Bipolar Indian-Origin Man Shot Dead By US Police

Advertisement
Continue Reading

Business

Gerber and Perrigo Face New Lawsuit Over ‘Store-Brand’ Infant Formula Pricing; All Pending Toxic Baby Food Cases Consolidated into New Class Action MDL

Published

on

Infant formula makers Gerber and Perrigo have been hit with a class-action lawsuit, which accuses the companies of artificially creating a shortage and jacking up prices for “store-brand” formula sold at Walmart, Walgreens, and other retailers.

The lawsuit was filed on Monday in federal court in Alexandria, Virginia. It accuses Perrigo of violating antitrust laws by collaborating with Gerber to prevent competitors from entering the market for store-brand formula.

Perrigo, one of the nation’s largest suppliers of store-brand formula, sells its products under retail labels at prices lower than similar branded products. However, the lawsuit alleges that Gerber, by granting Perrigo the first right of refusal to Gerber’s excess formula supply, which could have been sold to other competitors, is engaging in practices that stifle competition.

Advertisement

The lawsuit claims that through this arrangement, Gerber agreed to keep its excess formula out of the store-brand market, thereby gaining a share of Perrigo’s profits. The lawsuit was filed by four residents of California, Illinois, Michigan, and Pennsylvania, who will represent millions of customers who have purchased store-brand baby formula. The lawsuit does not name formula retailers as defendants. It asks the court to intervene and end the anticompetitive deals between Perrigo and Gerber and seeks more than $5 million in monetary damages.

This lawsuit is similar to another case filed in Brooklyn federal court by a potential store-brand competitor, P&L Development. Gerber and Perrigo requested the dismissal of that case, which was denied by the judge in February. The companies involved in the lawsuit claimed they compete fairly with other infant formula manufacturers, including those of store-brand formulas. The lawsuit also cited the squeezing out of P&L Development from the store-brand market, which has led to higher prices.

Gerber is also facing numerous lawsuits accusing its brands of baby food of containing dangerously high levels of toxic heavy metals, such as lead, arsenic, and mercury. These heavy metals are extremely toxic, even for adults, and can have catastrophic consequences on developing children, leading to health complications and neurological damage. Conditions such as ADHD and autism may be linked to consuming these toxic baby foods.

Advertisement

On April 11, 2024, all the lawsuits pertaining to toxic baby foods, which had been filed at different times in various courts, were consolidated into a new class action MDL in the Northern District of California and assigned to Judge Jacqueline Scott Corley. Besides Gerber, other baby food manufacturers like Beech-Nut and Campbell Soup Co. have also been named as defendants.

Also Read: Leading Ethereum Blockchain Entity Files Lawsuit Against SEC, Requests Court Declaration That Token Is Not a Security

Advertisement
Continue Reading

Business

Leading Ethereum Blockchain Entity Files Lawsuit Against SEC, Requests Court Declaration That Token Is Not a Security

Published

on

Leading Ethereum Blockchain Entity Files Lawsuit Against SEC, Requests Court Declaration That Token Is Not a Security

The legal wrangling between the crypto sector and the SEC, or the Securities and Exchange Commission, is getting uglier, with ConsenSys, a major protagonist of the Ethereum Blockchain, filing a lawsuit against the regulatory body in a Texas federal court. This legal action seeks an intervention to ward off a looming SEC lawsuit against the company regarding features of its popular MetaMask wallet. The lawsuit also seeks the court’s help in deciding once and for all the vexed question of whether Ethereum’s digital token, Ether, is not a security. The legal uncertainty hangs heavily on the crypto sector and puts a question mark on its very existence.

In an exhaustive 34-page legal filing, ConsenSys states that the SEC’s endeavor to exert control over Ethereum is both illegal and a threat to blockchain technology.

The complaint states,

Advertisement

“The SEC’s unlawful seizure of authority over ETH would spell disaster for the Ethereum network, and for ConsenSys. Every holder of ETH, including ConsenSys, would fear violating the securities laws if he or she were to transfer ETH on the network. This would bring the use of the Ethereum blockchain in the United States to a halt, crippling one of the internet’s greatest innovations.”

The lawsuit also alleges that SEC Chairman Gary Gensler has embarked on an aggressive enforcement policy directed at the big players in the crypto sector like Coinbase and Uniswap. The lawsuit particularly points out a campaign that involved a deluge of subpoenas asking firms and developers for documents related to their dealings with the nonprofit Ethereum Foundation, which supports the blockchain’s development.

The crypto sector is up in arms against Gensler’s tactics and has contended that the SEC has never provided clear rules meant for the distinct features of blockchain technology. However, Gensler negates this argument, saying that the existing securities laws are clear and sufficient, and that the crypto industry refuses to comply with them.

Gensler’s actions are full of contradictions since, in the past, the SEC had maintained that blockchain’s tokens, like Bitcoin, are not securities and hence beyond its purview. A senior official in 2018 had stated that Ethereum has reached a state where it is adequately decentralized, and further, the agency also gave the green signal for the launch of Ethereum futures trading—an implicit acknowledgement that Ether is a commodity. However, at present, Gensler is using a recent feature of Ethereum, known as staking, as grounds for the recent legal campaign.

Advertisement

The lawsuit was filed after the SEC issued a Wells Notice, which is akin to a formal letter warning that the agency intends to sue a firm and could lead to a settlement later. The SEC charged ConsenSys that MetaMask was operating as an unlicensed broker-dealer. MetaMask offered users a means to stake Ethereum on their behalf. Staking was a feature introduced in September 2022 on the Blockchain as a replacement for the energy-intensive mining process. The process involves a system of validators who pledge collateral to become trusted validators.

The SEC objects to the process of staking, which has changed Ethereum from a commodity into a security. ConsenSys founder Joe Lubin has called this account of the SEC “preposterous”.

Lubin said,

Advertisement

“The act of staking is really just posting a security bond so you can get paid to contribute labor and resources to help operate the Ethereum protocol. Now they’re trying to turn that into some sort of investment contract.”

Lubin also stated that the SEC’s actions will lead to a halt in the growth of the crypto sector and blockchain technology as a whole. Lubin feels that the SEC seeks to block pending applications by companies to launch spot ETFs for Ethereum, following the huge popularity of Bitcoin ETFs. The SEC is in fact trying to regulate a technology on its merits and it will only stifle innovation.

Also Read: New Class-Action Lawsuit Accuses Rivian of Making Materially False and Misleading Statements

Advertisement
Continue Reading

Trending

This will close in 5 seconds